Repeated ischemic stroke and its prevention

Author:

Pizova N. V.1ORCID,Pizov A. V.2ORCID

Affiliation:

1. Yaroslavl State Medical University

2. Yaroslavl State Pedagogical University named after K.D. Ushinsky

Abstract

Stroke is the world’s 2nd – 3rd leading cause of death and mortality. The risk of stroke is much greater for survivors of stroke. Survivors of a transient ischemic attack (TIA) or ischemic stroke are at higher risk of recurrent stroke during the interval between a few days or weeks and several years after the first event. Risk factors for ischemic stroke include hypertension, diabetes, hyperlipidemia, etc. The highest rate of recurrent stroke is observed in large artery atherosclerosis (atherothrombotic stroke) and cardioembolic stroke, while a recurrent stroke most often relates to the same subtype. A lacunar stroke is noted to have a lower recurrence rate, and a recurrent stroke may have a subtype that is different from the first one. In a recurrent stroke, neurological damage is usually more severe and harder to deal with. Patients with recurrent stroke have a higher mortality rate compared with patients with the first stroke. Secondary prevention is crucial to reduce recurrent ischemic stroke rates. To identify CVD risk factors is the initial priority when focusing efforts on secondary prevention. Lifestyle modifications, including tobacco cessation, decreased alcohol use, and increased physical activity, are also important in the management of patients with a history of stroke or transient ischemic attack. Optimal pharmacotherapeutic preventive strategies should be tailored to the specific stroke subtype. Antiplatelet therapy is recommended to reduce the risk of recurrent ischemic stroke, and its choice should be based on treatment duration, safety, efficacy, the cost of the drug, and patient characteristics and preferences.

Publisher

Remedium, Ltd.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3